Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade
International Journal of Molecular Sciences · 16.11.2023 · 24 (22) · 16382
DOI: 10.3390/ijms242216382 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.11.2023. Verfasst von Saba Khoshbakht und 3 weiteren Autor:innen. Beteiligte Einrichtung: Koç University Research Center for Translational Medicine, Istanbul 34010, Turkey. Hauptthemen laut MEDLINE: Behcet Syndrome. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TUBITAK, European Academy of Dermatology and Venereology, EADV.
Abstract (Originalsprache)
Behçet’s disease (BD) is a complex, recurring inflammatory disorder with autoinflammatory and autoimmune components. This comprehensive review aims to explore BD’s pathogenesis, focusing on established genetic factors. Studies reveal that HLA-B*51 is the primary genetic risk factor, but non-HLA genes (ERAP1, IL-10, IL23R/IL-12RB2), as well as innate immunity genes (FUT2, MICA, TLRs), also contribute. Genome-wide studies emphasize the significance of ERAP1 and HLA-I epistasis. These variants influence antigen presentation, enzymatic activity, and HLA-I peptidomes, potentially leading to distinct autoimmune responses. We conducted a systematic review of the literature to identify studies exploring the association between HLA-B*51 and BD and further highlighted the roles of innate and adaptive immunity in BD. Dysregulations in Th1/Th2 and Th17/Th1 ratios, heightened clonal cytotoxic (CD8+) T cells, and reduced T regulatory cells characterize BD’s complex immune responses. Various immune cell types (neutrophils, γδ T cells, natural killer cells) further contribute by releasing cytokines (IL-17, IL-8, GM-CSF) that enhance neutrophil activation and mediate interactions between innate and adaptive immunity. In summary, this review advances our understanding of BD pathogenesis while acknowledging the research limitations. Further exploration of genetic interactions, immune dysregulation, and immune cell roles is crucial. Future studies may unveil novel diagnostic and therapeutic strategies, offering improved management for this complex disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Koç University Research Center for Translational Medicine, Istanbul 34010, Turkey.
- School of Medicine, Koç University, Istanbul 34010, Turkey.
- Department of Neurology, Koç University School of Medicine, Istanbul 34010, Turkey.
- Department of Dermatology and Venereology, Koç University School of Medicine, Istanbul 34010, Turkey.
ORCID-Profile: Saba Khoshbakht, Defne Başkurt, Atay Vural, Seçil Vural
Förderung
- TUBITAK
- European Academy of Dermatology and Venereology
- EADV
- TÜBİTAK 1001
Zitieren
APA
Khoshbakht, S., Başkurt, D., Vural, A., & Vural, S. (2023). Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade. International Journal of Molecular Sciences, 24(22), 16382. https://doi.org/10.3390/ijms242216382
Vancouver
Khoshbakht S, Başkurt D, Vural A, Vural S. Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade. International Journal of Molecular Sciences. 2023;24(22):16382. doi:10.3390/ijms242216382
BibTeX
@article{Khoshbakht2023,
author = {Khoshbakht, Saba and Başkurt, Defne and Vural, Atay and Vural, Seçil},
title = {Behçet’s Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {22},
pages = {16382},
doi = {10.3390/ijms242216382}
}
EUVIMED